Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $41.53 ($415K) on 2018-11-05, disclosed to the SEC on 2018-11-07.
Open-market sale of $415k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |